esqLABS is a CRO providing consulting, software development and training for PBPK/PD modeling and simulation with PK-Sim® and MoBi® #OSPSuite #PKSim #MoBi #QSP

Lower Saxony, Germany
Very happy that esqLABS GmbH is part of this European Food Safety Authority (EFSA) Roadmap Development for aggregate exposure risk assessment with Alicia Paini and Lara Lamon lnkd.in/dG6sKAiM
2
111
Excited to connect with both familiar and new faces in the industry to exchange ideas on computational approaches for #NAM and #NGRA. 🤝 Let's work together to explore new possibilities and collaborate. Do not hesitate to contact me! 📲 lnkd.in/ghN-YTes
1
45
📢#joboffer Looking for a new opportunity in the exciting field of #PBPK, #PBK, and #PBTK? Our team at #esqLABS is seeking a highly experienced #quantitativepharmacology and #MIDD enthusiast to join us in shaping the future of regulatory applications in a…lnkd.in/eeJUisrQ
1
66
👀 Only two years that feel like 5 💪🏼. Much has been done! 👩🏻‍💻 Within #ONTOX esqLABS GmbH is working towards an #integrated (low and high-throughput) #PBK - #qAOP framework for predictions of adverse outcome ⚠️ and #QIVIVE reverse dosimetry. lnkd.in/dsgV7Di4
1
32
PM me for a meetup in Berlin on #PBPK #QSP the #OSPSuite (#PKSim and #MoBi) and its vast value for your #MIDD strategy! lnkd.in/dk-FwJ5N
1
34
📢#joboffer Are you #leading 👨‍🚀👩‍💻 #midd and #quantitativepharmacology in the area of #reguatory applications of #PBPK and #QSP? #join our #team to embark on a new era in shaping #science and #solutions in #quantitativepharmacology with #opencollabor…lnkd.in/eCsSiUXE
43
📢 #ASCPT #Today Poster Session II, Thursday, March 23, 5:00-6:30 pm local time --> PII-094  📰 #poster on cholesterol metabolism and how that can be used as an indication for #CYP3A4 #induction studies (#DDI) lnkd.in/gzWS67MX
34